Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Medication Trials

Michigan

CNS medication trials in Michigan

63 CNS medication studies are recruiting participants at sites in 16 cities across Michigan as of November 17, 2026, according to ClinicalTrials.gov.

Call (888) 927-5768
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Michigan city with a recruiting study

By research area: Parkinson's Disease (20), Migraine (10), Multiple Sclerosis (10), Depression (9), Epilepsy (7), ADHD (3), Schizophrenia (3), Bipolar Disorder (1).

Ann Arbor (28), Farmington Hills (16), Grand Rapids (7), Detroit (6), Bloomfield Hills (4), Rochester Hills (3), Farmington (2), Troy (2), Bloomfield Township (1), East Lansing (1), Livonia (1), Memphis (1), Novi (1), Owosso (1), Royal Oak (1), Southfield (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in Michigan

Basic details from each study's public record (the 12 most recently updated of 63). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

    • Phase 2
    • Ages 18 to 80
    • All sexes
    Sponsor
    Reunion Neuroscience Inc
    Recruiting in
    Ann Arbor · Novi
    Registry record
    NCT07002034 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Michigan on ClinicalTrials.gov.

Parkinson's disease: recently updated in Michigan

  1. A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Grand Rapids
    Registry record
    NCT06841354 · updated
  2. DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    AstraZeneca
    Recruiting in
    Ann Arbor
    Registry record
    NCT06989112 · updated
  3. Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Grand Rapids
    Registry record
    NCT06469944 · updated
  4. Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments

    • Phase 1/2
    • Ages 45 and older
    • All sexes
    Sponsor
    Prabesh Kanel
    Recruiting in
    Ann Arbor
    Registry record
    NCT07154511 · updated
  5. A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations

    • Phase 2
    • Ages 40 to 85
    • All sexes
    Sponsor
    H. Lundbeck A/S
    Recruiting in
    Farmington
    Registry record
    NCT07514858 · updated
  6. SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

    • Phase 1
    • Ages 40 to 80
    • All sexes
    Sponsor
    Serina Therapeutics
    Recruiting in
    Farmington Hills
    Registry record
    NCT07422675 · updated
  7. A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Vima Therapeutics
    Recruiting in
    Farmington Hills
    Registry record
    NCT07804615 · updated
  8. A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

    • Phase 3
    • Ages 50 to 85
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Farmington Hills
    Registry record
    NCT07174310 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Michigan on ClinicalTrials.gov.

Multiple sclerosis (MS): recently updated in Michigan

  1. A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

    • Phase 3
    • Ages 18 to 60
    • All sexes
    Sponsor
    Zenas BioPharma (USA), LLC
    Recruiting in
    Rochester Hills
    Registry record
    NCT07299019 · updated
  2. A Study of AZD0120 in Autoimmune Diseases

    • Phase 1/2
    • Ages 18 to 75
    • All sexes
    Sponsor
    AstraZeneca
    Recruiting in
    Ann Arbor
    Registry record
    NCT07295847 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Michigan on ClinicalTrials.gov.

Migraine: recently updated in Michigan

  1. Study of EVO756 in Adults With Migraine

    • Phase 2
    • Ages 18 to 64
    • All sexes
    Sponsor
    Evommune, Inc.
    Recruiting in
    Ann Arbor · Farmington Hills
    Registry record
    NCT07616128 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Michigan on ClinicalTrials.gov.

Ask about studies in Michigan

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.

CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5768

or send a short form

How should we reach you?

Call